Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2).
Lukaschek
J
J
Nephrology, Department Internal Medicine, University Hospital Zürich, Zürich, Switzerland.
Hofmann
J
J
Aerne
D
D
Ambühl
P
P
Kistler
T
T
Knoflach
A
A
Pei
P
P
Binswanger
U
U
D000284:Administration, Oral; D019540:Area Under Curve; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D007408:Intestinal Absorption; D016030:Kidney Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine